McCabe Vision Center

Quick facts

Phase 1 pipeline

• Bepotastine besilate ophthalmic solution 1.5% · Ophthalmology
  12.1 Mechanism of Action Bepotastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• McCabe Vision Center portfolio CI brief
• McCabe Vision Center pipeline updates RSS